Dr Trevor Perrior

Research Director

 

Following academic research at Cambridge, Oxford and in the USA, Trevor held a number of senior R&D roles in the pharmaceutical and biotechnology companies ICI, Zeneca, AstraZeneca and Celltech, working on sites in the UK, USA, and Switzerland.  Trevor has led teams that have delivered numerous development candidates across several therapeutic areas.  In 2005 he joined NCE Discovery as Chief Scientific Officer, and when NCE Discovery merged with Domainex he became Research Director of the enlarged company.  Trevor is also a scientific consultant to a number of venture capital and charitable funds.